Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


View Clinical Trials from BioPharm Insight

 Company News
Celsion Corporation (CLSN) Announces Highlights From Three Presentations Given At The International Liver Cancer Association 2014 Annual Conference 9/8/2014 9:24:34 AM
Celsion Corporation (CLSN) Reports Consolidated Duke University And Celsion's DIGNITY Study Clinical Data On Thermodox® In Recurrent Chest Wall Breast Cancer Published In The International Journal Of Hyperthermia 9/5/2014 10:48:50 AM
Celsion Corporation (CLSN) Announces Enrollment Of First Patient In Global Phase 3 OPTIMA Study Of Thermodox® In Primary Liver Cancer 9/3/2014 11:19:12 AM
Celsion Corporation (CLSN) To Present At Rodman & Renshaw 16th Annual Healthcare Conference 8/28/2014 1:31:36 PM
Celsion Corporation (CLSN) To Present At The Rodman & Renshaw 16th Annual Healthcare Conference 8/28/2014 1:31:05 PM
Celsion Corporation (CLSN) Reports Second Quarter 2014 Financial Results 8/7/2014 9:47:01 AM
Celsion Corporation (CLSN) To Hold Second Quarter 2014 Financial Results 7/31/2014 9:39:43 AM
Celsion Corporation (CLSN) Shows Off Positive ThermoDox® Data In Primary Liver Cancer Patients 7/28/2014 8:15:50 AM
Celsion Corporation (CLSN) Announces Positive Interim Data Update From Its Phase 2 DIGNITY Study In Breast Cancer 7/24/2014 8:04:06 AM
Celsion Corporation (CLN) Announces $1 Million National Institutes of Health (NIH), NIBIB. - Career Development Award Grant For Glioblastoma Research With Thermodox® And HIFU 7/21/2014 12:43:52 PM